New Delhi, March 27 Biocon Ltd announced on Friday that Shreehas Tambe has been appointed as CEO & Managing Director, effective April 1, 2026.As the first CEO of the integrated Biocon, he will lead the combined platform encompassing biosimilars and generics, strengthening the company's ability...
New Delhi, February 12 Biocon announced on Thursday a more than five-fold increase in consolidated net profit to Rs 144 crore for the quarter ended December 2025, driven by gains in its generics and biosimilar business segments.The Bengaluru-based company reported a net profit of Rs 25 crore...